Novugen focuses on complex generics and difficult to develop products in all therapeutic areas of oncology and general medicine. Through our passionate teams, we aim to provide early access to the highest quality medicine with continuous investment in R&D. Our accreditations include USFDA approvals which amplify our quality standards.
Solid Oral dosage forms (Tablets, Capsules, Powders, Sachets, Pellets and Beads)
Parenteral dosage forms (Liquid and Lyophilized powders)
Complex generics (Modified Release, Bilayer, MUPS and OCAS)
Our portfolio consists of technology intensive products in a wide range of disease areas.
Over 70 complex Finished Products
Active Pharmaceutical Ingredients (API) products under development and registration in various regions